Skip to main content

Brucellosis: It is not only Malta!

  • Chapter
  • First Online:
Zoonoses - Infections Affecting Humans and Animals

Abstract

Brucellosis is caused by one of the ten species of the genus Brucella, of which only several can cause human disease. It is among the most widespread zoonoses in the World. The disease is transmitted to humans by contact with fluids from infected animals or derived food products. The mechanisms by which brucellae manifest their pathogenic features are complex. Lipopolysaccharide (LPS) has a role in evasion of the infected cell and is essential for intracellular survival. Brucellae invade and persist in the host via inhibition of programmed cell death. Despite the high degree of DNA homology within the Brucella genus, molecular typing schemes based on the use of multiple locus variable number of tandem repeats analysis (MLVA) have proven to be able to differentiate unrelated Brucella isolates which could not be differentiated by classical microbiological methods. Due to its high discriminatory power, MLVA has been successfully used for identification of human outbreaks related with a same source of infection, as well as for confirmation of relapse and laboratory acquired infection. Prevention of human brucellosis may be based on prevention of transmission from animal reservoirs to humans and control or eradication of the infection in the reservoir population. Control and prevention programs in animal brucellosis require effective collaboration between all sections of the community and must be properly planned, coordinated and resourced.

In spite of the huge knowledge on the disease until now, many aspects are not yet clarified, like actual taxonomy and the durability and solidness of the immune response after the disease. Also, there is the need of development of better diagnostic techniques and therapeutical options. The production of an effective and acceptable vaccine for use in humans remains as a special challenge in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Al Dahouk S, Nockler K (2011) Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther 9:833–845. doi:10.1586/eri.11.55

    Article  CAS  PubMed  Google Scholar 

  • Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D (2003) Laboratory-based diagnosis of brucellosis—a review of the literature. Part II: serological tests for brucellosis. Clin Lab 49:577–589

    PubMed  Google Scholar 

  • Al Dahouk SN, Hagen RM et al (2005a) Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003. Eur J Clin Microbiol Infect Dis 24:450–456

    Google Scholar 

  • Al Dahouk SH, Scholz HC et al (2005b) Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. Chemotherapy 51:352–356

    Google Scholar 

  • Al Dahouk SF, Scholz HC et al (2007) Evaluation of Brucella MLVA typing for human brucellosis. J Microbiol Methods 69:137–145

    Article  CAS  PubMed  Google Scholar 

  • Al Dahouk SS, Karges W et al (2010) Differential phenotyping of Brucella species using a newly developed semi-automated metabolic system. BMC Microbiol 10:269. doi: 10.1186/1471-2180-10-269

    Article  PubMed Central  PubMed  Google Scholar 

  • Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH (2001) Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology 6:317–322

    Article  CAS  PubMed  Google Scholar 

  • Al-Shamahy HA, Wright SG (1998) Enzyme-linked immunosorbent assay for brucella antigen detection in human sera. J Med Microbiol 47:169–172

    Article  CAS  PubMed  Google Scholar 

  • Araj GF (1999) Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin Lab Sci 12:207–212

    CAS  PubMed  Google Scholar 

  • Araj GF, Kattar MM (2003) Rapid diagnosis of human brucellosis using the bact/alert continuous culture monitoring system. Abstr 103rd Annu Meet Am Soc Microbiol abstract C-200

    Google Scholar 

  • Ariza J, Pellicer T, Pallares R, Foz A, Gudiol F (1992) Specific antibody profile in human brucellosis. Clin Infect Dis 14:131–140

    Article  CAS  PubMed  Google Scholar 

  • Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME et al (2007) Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 4:e317. doi:10.1371/journal.pmed.0040317

    Article  PubMed Central  PubMed  Google Scholar 

  • Baldi PC, Miguel SE, Fossati CA, Wallach JC (1996) Serological follow-up of human brucellosis by measuring IgG antibodies to lipopolysaccharide and cytoplasmic proteins of Brucella species. Clin Infect Dis 22:446–455

    Article  CAS  PubMed  Google Scholar 

  • Baldwin CL, Parent M (2002) Fundamentals of host immune response against brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol 90:367–382

    Article  CAS  PubMed  Google Scholar 

  • Banai M (2010) Insights into the problem of B. Melitensis and rationalizing a vaccination programme in Israel. Prilozi 31:167–180

    CAS  PubMed  Google Scholar 

  • Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chacon-Díaz C, Rucavado A et al (2007) Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2:e631. doi:10.1371/journal.pone.0000631

    Article  PubMed Central  PubMed  Google Scholar 

  • Bertrand A (1994) Antibiotic treatment of brucellosis. Presse Med 23:1128–1131

    CAS  PubMed  Google Scholar 

  • Blasco JM (2010) Control and eradication strategies for brucella melitensis infection in sheep and goats. Prilozi 31:145–165

    CAS  PubMed  Google Scholar 

  • Bosilkovski M, Krteva L, Caparoska S, Dimzova M (2004) Osteoarticular involvement in Brucellosis: study of 196 cases in the Republic of Macedonia. Croat Med J 45:727–733

    PubMed  Google Scholar 

  • Bosilkovski M, Krteva L, Dimzova M, Kondova I (2007) Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 11:342–347

    Article  CAS  PubMed  Google Scholar 

  • Bosilkovski M, Katerina S, Zaklina S, Ivan V (2010a) The role of Brucellacapt test for follow-up patients with brucellosis. Comp Immunol Microbiol Infect Dis 33:435–442. doi:10.1016/j.cimid.2009.06.001

    Google Scholar 

  • Bosilkovski M, Krteva L, Dimzova M, Vidinic I, Sopova Z, Spasovska K (2010b) Human brucellosis in Macedonia—10 years of clinical experience in endemic region. Croat Med J 51:327–336

    Google Scholar 

  • Bricker BJ, Halling SM (1994) Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol 32:2660–2666

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bricker BJ, Ewalt DR (2005) Evaluation of the HOOF-Print assay for typing Brucella abortus strains isolated from cattle in the United States: results with four performance criteria. BMC Microbiol 5:37. doi:10.1186/1471-2180-5-37

    Article  PubMed Central  PubMed  Google Scholar 

  • Bricker BJ, Ewalt DR, Halling SM (2003) Brucella ‘HOOF-Prints’: strain typing by multi-locus analysis of variable number tandem repeats (VNTRs). BMC Microbiol 3:15. doi:10.1186/1471-2180-3-15

    Article  PubMed Central  PubMed  Google Scholar 

  • Buchanan TM, Sulzer CR, Frix MK, Feldman RA (1974) Brucellosis in the United States, 1960–1972. An abattoir-associated disease. Part II. Diagnostic aspects. Medicine (Baltimore) 53:415–425

    Article  CAS  Google Scholar 

  • Chevrel J, Riojas A, Lafargues JP, Sarlangue J, Barbier R (2001) Osteoarticular brucellosis and signs of autoimmunity. Arch Pediatr 8:834–837

    Article  CAS  PubMed  Google Scholar 

  • Comerci DJ, Altabe S, de Mendoza D, Ugalde RA (2006) Brucella abortus synthesizes phosphatidylcholine from choline provided by the host. J Bacteriol 188:1929–1934

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Corbel MJ (1997) Brucellosis: an overview. Emerg Infect Dis 3:213–221

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cosivi O (1998) Animal brucellosis surveillance and control in the mediterranean and middle east countries. In: The MZCP report on the third workshop on human and animal Brucellosis Epidemiological Surveillance in the MZCP countries. Damascus, Syrian Arab Republic

    Google Scholar 

  • Cutler SJ, Whatmore AM, Commander NJ (2005) Brucellosis-new aspects of an old disease. J Appl Microbiol 98:1270–1281

    Article  CAS  PubMed  Google Scholar 

  • El-Tras WF, Tayel AA, Eltholth MM, Guitian J (2010) Brucella infection in fresh water fish: evidence for natural infection of Nile catfish, Clarias gariepinus, with Brucella melitensis. Vet Microbiol 141:321–325. doi:10.1016/j.vetmic.2009.09.017

    Article  CAS  PubMed  Google Scholar 

  • Falagas ME, Bliziotis IA (2006) Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother 50:22–33

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fiori PL, Mastrandrea S, Rappelli P, Cappuccinelli P (2000) Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol 38:2005–2006

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gad El-Rab MO, Kambal AM (1998) Evaluation of a Brucella enzyme immunoassay test (ELISA) in comparison with bacteriological culture and agglutination. J Infect 36:197–201

    Article  CAS  PubMed  Google Scholar 

  • Ganguly R (1984) Brucella: brucellosis. In: Waldman RH, Kluge RM (eds) Infectious diseases. Medical Examination Publishing Co, New York, pp 807–811

    Google Scholar 

  • Garcia-Yoldi D, Marin CM, de Miguel MJ, Munoz PM, Vizmanos JL, Lopez-Goni I (2006) Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clin Chem 52:779–781. doi:10.1373/clinchem.2005.062596

    Article  CAS  PubMed  Google Scholar 

  • Gazapo E, Gonzalez Lahoz J, Subiza JL, Baquero M, Gil J, de la Concha EG (1989) Changes in IgM and IgG antibody concentrations in Brucellosis over time: importance for diagnosis and follow-up. J Infect Dis 159:219–225

    Article  CAS  PubMed  Google Scholar 

  • Ghanem YM, El-Khodery SA, Saad AA, Abdelkader AH, Heybe A, Musse YA (2009) Seroprevalence of camel brucellosis (Camelus dromedarius) in Somaliland. Trop Anim Health Prod 41:1779–1786. doi:10.1007/s11250-009-9377-9

    Article  PubMed  Google Scholar 

  • Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K et al (2005) From the discovery of the Malta fever’s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res 36:313–326

    Article  PubMed  Google Scholar 

  • Godfroid J, Nielsen K, Saegerman C (2010) Diagnosis of Brucellosis in livestock and wildlife. Croat Med J 51:296–305. doi:10.3325/cmj.2010.51.296

    Article  PubMed Central  PubMed  Google Scholar 

  • Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D et al (2011) Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med 102:118–131. doi:10.1016/j.prevetmed.2011.04.007

    Article  CAS  PubMed  Google Scholar 

  • Gomez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Munoz A et al (2008) Evaluation of seven tests for the diagnosis of human brucellosis in an endemic area. Clin Vaccine Immunol 15:1031–1033

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gorvel JP (2008) Brucella: a Mr “Hide” converted into Dr Jekyll. Microbes Infect 10:1010–1013. doi:10.1016/j.micinf.2008.07.007

    Article  PubMed  Google Scholar 

  • Gorvel JP, Moreno E (2002) Brucella intracellular life: from invasion to intracellular replication. Vet Microbiol 90:281–297

    Article  CAS  PubMed  Google Scholar 

  • Gotuzzo E (1999) Brucellosis. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases. Principles, pathogens, and practice. Churchill Livingstone, Philadelphia, pp 498–505

    Google Scholar 

  • Gotuzzo E, Carillo C (2004) Brucella. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1837–1845

    Google Scholar 

  • Gotuzzo E, Carrillo C, Guerra J, Llosa L (1986) An evaluation of diagnostic methods for brucellosis—the value of bone marrow culture. J Infect Dis 153:122–125

    Article  CAS  PubMed  Google Scholar 

  • Issa H, Jamal M (1999) Brucellosis in children in south Jordan. East Mediterr Health J 5:895–902

    CAS  PubMed  Google Scholar 

  • Jergefa T, Kelay B, Bekana M, Teshale S, Gustafson H, Kindahl H (2009) Epidemiological study of bovine brucellosis in three agro-ecological areas of central Oromiya, Ethiopia. Rev Sci Tech 28:933–943

    CAS  PubMed  Google Scholar 

  • Kasimova HA, Rentzova MM (1979) Reinfection in brucellosis. Zh Mikrobiol Epidemiol Immunobiol 6:105–109

    Google Scholar 

  • Kumar A (2010) Brucellosis: need of public health intervention in rural India. Prilozi 31:219–231

    CAS  PubMed  Google Scholar 

  • Lamontagne J, Beland M, Forest A, Cote-Martin A, Nassif N, Tomaki F et al (2010) Proteomics-based confirmation of protein expression and correction of annotation errors in the Brucella abortus genome. BMC Genomics 11:300. doi:10.1186/1471-2164-11-300

    Article  PubMed Central  PubMed  Google Scholar 

  • Le Fleche PJ, Denoeud F et al (2006) Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol 6:9. doi:10.1186/1471-2180-6-9

    Article  PubMed Central  PubMed  Google Scholar 

  • Lindquist D, Chu MC, Probert WWS (2007) Francisella and Brucella. In: Murray PR, Baron EJO, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, 9th edn. ASM, Washington, pp 824–834

    Google Scholar 

  • Mantur BG, Amarnath SK, Shinde RS (2007) Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25:188–202

    Article  CAS  PubMed  Google Scholar 

  • Marianelli C, Petrucca A, Pasquali P, Ciuchini F, Papadopoulou S, Cipriani P (2008) Use of MLVA-16 to trace the source of a laboratory-acquired Brucella infection. J Hosp Infect 68:274–276. doi:10.1016/j.jhin.2008.01.003

    Article  CAS  PubMed  Google Scholar 

  • Melzer F, Al Dahouk S, Neubauer H, Mettenleiter TC (2007) Increasing incidence in neighboring EU States. Is brucellosis about to become a travel medicine problem? MMW Fortschr Med 149:46–47

    CAS  PubMed  Google Scholar 

  • Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO (2002) Comparison of the Brucella standard agglutination test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis 44:129–132

    Article  CAS  PubMed  Google Scholar 

  • Morelli D (1998) General considerations on the epidemiological surveillance and control of brucellosis. In: The MZCP report on the third workshop on human and animal Brucellosis Epidemiological Surveillance in the MZCP countries. Damascus, Syrian Arab Republic

    Google Scholar 

  • Moreno E, Moriyon I (2002) Brucella melitensis: a nasty bug with hidden credentials for virulence. Proc Natl Acad Sci U S A 99:1–3

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Morgan WJ, MacKinnon DJ, Lawson JR, Cullen GA (1969) The rose bengal plate agglutination test in the diagnosis of brucellosis. Vet Rec 85:636–641

    CAS  PubMed  Google Scholar 

  • Muma JB, Samui KL, Oloya J, Munyeme M, Skjerve E (2007) Risk factors for brucellosis in indigenous cattle reared in livestock-wildlife interface areas of Zambia. Prev Vet Med 80:306–317

    Article  CAS  PubMed  Google Scholar 

  • Navarro E, Segura JC, Castano MJ, Solera J (2006) Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 42:1266–1273

    Article  CAS  PubMed  Google Scholar 

  • Neubauer H (2010) Brucellosis: new demands in a changing world. Prilozi 31:209–217

    CAS  PubMed  Google Scholar 

  • Nicoletti P (2010) Brucellosis: past, present and future. Prilozi 31:21–32

    CAS  PubMed  Google Scholar 

  • Nielsen K, Yu WL (2010) Serological diagnosis of brucellosis. Prilozi 31:65–89

    CAS  PubMed  Google Scholar 

  • Pappas G, Akritidis N, Bosilkovski M, Tsianos E (2005) Brucellosis. N Engl J Med 352:2325–2336

    Article  CAS  PubMed  Google Scholar 

  • Pappas G, Panagopoulou P, Christou L, Akritidis N (2006a) Brucella as a biological weapon. Cell Mol Life Sci 63:2229–2236

    Google Scholar 

  • Pappas G, Papadimitriou P, Christou L, Akritidis N (2006b) Future trends in human brucellosis treatment. Expert Opin Investig Drugs 15:1141–1149

    Google Scholar 

  • Pappas G, Papadimitrou PH, Akritidis N, Christou L, Tsianos EV (2006c) The new global map of human brucellosis. Lancet Infect Dis 6:91–99

    Google Scholar 

  • Payne DJ (1974) Chronic brucellosis. Br Med J 2:221–222

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Robinson A (1998) Critical issues in designing and evaluating a surveillance system. In: The MZCP report on the third workshop on human and animal Brucellosis Epidemiological Surveillance in the MZCP countries. Damascus, Syrian Arab Republic

    Google Scholar 

  • Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A (2010) Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis 14:e250–e253. doi:10.1016/j.ijid.2009.05.008

    Article  PubMed  Google Scholar 

  • Simpson WM (1941) Brucellosis. Bull NY Acad Med 17:592–617

    CAS  Google Scholar 

  • Skendros P, Sarantopoulos A, Tselios K, Boura P (2008) Chronic brucellosis patients retain low frequency of CD4+ T-lymphocytes expressing CD25 and CD28 after Escherichia coli LPS stimulation of PHA-cultured PBMCs. Clin Dev Immunol 2008:327346. doi:10.1155/2008/327346

    Article  PubMed Central  PubMed  Google Scholar 

  • Skendros P, Pappas G, Boura P (2011) Cell-mediated immunity in human brucellosis. Microbes Infect 13:134–142. doi:10.1016/j.micinf.2010

    Article  CAS  PubMed  Google Scholar 

  • Sohn AH, Probert WS, Glaser CA, Gupta N, Bollen AW, Wong JD et al (2003) Human neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 9:485–488

    Article  PubMed Central  PubMed  Google Scholar 

  • Solera J, Rodriguez-Zapata M, Geijo P, Largo J, Paulino J, Saez L et al (1995) Doxycycline-Rifampin versus Doxycycline-Streptomycin in treatment of human Brucellosis due to Brucella melitensis. GECMEI group. Antimicrob Agents Chemother 39:2061–2067

    Google Scholar 

  • Stoffregen WC, Olsen SC, Jack Wheeler C, Bricker BJ, Palmer MV, Jensen AE et al (2007) Diagnostic characterization of a feral swine herd enzootically infected with Brucella. J Vet Diagn Invest 19:227–237

    Article  PubMed  Google Scholar 

  • Verger JM, Grimont F, Grimont PAD, Grayon M (1985) Brucella, a monospecific genus as shown by deoxyribonucleic-acid hybridization. Int J Syst Bacteriol 35:292–295

    Article  Google Scholar 

  • Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46:e131–e136. doi:10.1086/588482

    Article  PubMed  Google Scholar 

  • World Health Organization (2006) Brucellosis in human and animals. World Health Organization, Geneva, WHO/CDS/EPR/2006.7

    Google Scholar 

  • Wright SG (2000) Brucellosis. In: Strickland GT (ed) Hunter’s tropical medicine and emerging infectious diseases, 8th edn. Saunders Company, Philadelphia, pp 416–420

    Google Scholar 

  • Yagupsky P (1999) Detection of Brucellae in blood cultures. J Clin Microbiol 37:3437–3442

    CAS  PubMed Central  PubMed  Google Scholar 

  • Young EJ (1995) An overview of human brucellosis. Clin Infect Dis 21:283–290

    Article  CAS  PubMed  Google Scholar 

  • Zhan Y, Cheers C (1995) Endogenous interleukin-12 is involved in resistance to brucella abortus infection. Infect Immun 63:1387–1390

    CAS  PubMed Central  PubMed  Google Scholar 

  • Zhan Y, Liu Z, Cheers C (1996) Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 64:2782–2786

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mile Bosilkovski MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bosilkovski, M. (2015). Brucellosis: It is not only Malta!. In: Sing, A. (eds) Zoonoses - Infections Affecting Humans and Animals. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9457-2_11

Download citation

Publish with us

Policies and ethics